![PDF) Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers PDF) Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers](https://i1.rgstatic.net/publication/282037952_Prognostic_value_of_BRAF_and_KRAS_mutation_status_in_stage_II_and_III_microsatellite_instable_colon_cancers/links/5a65c8a40f7e9b6b8fdcaf1b/largepreview.png)
PDF) Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers
![PDF) The role of green supply chain management practices on environmental performance in the hydrocarbon industry of Bahrain: Testing the moderation of green innovation PDF) The role of green supply chain management practices on environmental performance in the hydrocarbon industry of Bahrain: Testing the moderation of green innovation](https://www.researchgate.net/profile/Saad-Darwish-4/publication/350615787/figure/tbl2/AS:1023328345149443@1620991898203/Path-analysis_Q320.jpg)
PDF) The role of green supply chain management practices on environmental performance in the hydrocarbon industry of Bahrain: Testing the moderation of green innovation
![PDF) The role of green supply chain management practices on environmental performance in the hydrocarbon industry of Bahrain: Testing the moderation of green innovation PDF) The role of green supply chain management practices on environmental performance in the hydrocarbon industry of Bahrain: Testing the moderation of green innovation](https://www.researchgate.net/profile/Saad-Darwish-4/publication/350615787/figure/tbl1/AS:1023328345128962@1620991898177/Convergent-validity_Q320.jpg)
PDF) The role of green supply chain management practices on environmental performance in the hydrocarbon industry of Bahrain: Testing the moderation of green innovation
![BusinessWire - Celgene Corporation (CG3) FDA Grants Approval of IDHIFA®, the First Oral Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH2 Mutation | ResearchPool BusinessWire - Celgene Corporation (CG3) FDA Grants Approval of IDHIFA®, the First Oral Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH2 Mutation | ResearchPool](https://mms.businesswire.com/media/20170801006281/en/604221/4/AML_infographic_8117---FINAL.jpg)
BusinessWire - Celgene Corporation (CG3) FDA Grants Approval of IDHIFA®, the First Oral Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH2 Mutation | ResearchPool
![PDF) The role of green supply chain management practices on environmental performance in the hydrocarbon industry of Bahrain: Testing the moderation of green innovation PDF) The role of green supply chain management practices on environmental performance in the hydrocarbon industry of Bahrain: Testing the moderation of green innovation](https://i1.rgstatic.net/publication/350615787_The_role_of_green_supply_chain_management_practices_on_environmental_performance_in_the_hydrocarbon_industry_of_Bahrain_Testing_the_moderation_of_green_innovation/links/60e529bb92851c2b83e4f2e0/largepreview.png)